MedTrace Logo

Clinical Evaluation of Two Silicone Hydrogel Contact Lenses

NCT05313412 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2023-05-09

Study results available
· View outcomes & findings →

Summary

This study is to compare the short-term clinical performance and subjective acceptance of two silicone hydrogel soft contact lenses.

Conditions

  • Myopia

Interventions

DEVICE

Lens A (comfilcon A lens)

6 hours

DEVICE

Lens B (lehfilcon A lens)

6 hours

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Philip Morgan, PhD,MCOptom · Eurolens Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-27
Primary Completion
2022-04-21
Completion
2022-04-21
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05313412 on ClinicalTrials.gov